MUNJOVI
Live / Registered — Registered (as of 25 Jan 2022)
What this means for you
Registered since 25 Jan 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90261241
- Registration number
- 6625339
- Mark type
- Stylized text
- Filed
- 17 Oct 2020
- Published for opposition
- 09 Nov 2021
- Registered
- 25 Jan 2022
- Attorney of record
- Frances M. Jagla
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals and pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines; diagnostic preparations for medical purposes; biological substances for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; Biological preparations for medical purposes for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields; research and development of medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research, clinical research in the field of antibodies and pharmaceuticals, and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies
Owner
- INCYTE HOLDINGS CORPORATION, WILMINGTON, DE, US
- MorphoSys AG, Planegg, DE
- MorphoSys AG, Planegg, DE
- MorphoSys AG, Planegg, DE
Prosecution history
- 17 Jun 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Jun 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 17 Jun 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 17 Jun 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 17 Jun 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 31 Jan 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 25 Jan 2022 — REGISTERED-PRINCIPAL REGISTER
- 09 Nov 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Nov 2021 — PUBLISHED FOR OPPOSITION
- 20 Oct 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Oct 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Sept 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Sept 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Sept 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 26 Mar 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED